GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (OTCPK:ORYZF) » Definitions » Purchase Of Investment

ORYZF (Oryzon Genomics) Purchase Of Investment : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Oryzon Genomics Purchase Of Investment?

Oryzon Genomics's purchase of investment for the three months ended in Sep. 2024 was $0.00 Mil. It means Oryzon Genomics spent $0.00 Mil on purchasing investments. Oryzon Genomics's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), Oryzon Genomics spent the same money on purchasing investments in Sep. 2024 ($0.00 Mil).

Oryzon Genomics Purchase Of Investment Historical Data

The historical data trend for Oryzon Genomics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Purchase Of Investment Chart

Oryzon Genomics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.50 - -0.01 - -

Oryzon Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oryzon Genomics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (OTCPK:ORYZF) » Definitions » Purchase Of Investment
Comparable Companies
XMAD:BST XMAD:ATRY XMAD:PHM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB
Traded in Other Exchanges
0RDB:UK ORY:Spain ORN:Germany
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Website
http://www.oryzon.com
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.